Low-dose cyclophosphamide combined with standard immunosuppressive therapy improves early response rates in severe aplastic anemia
Low-dose CTX combined with standard IST appears to improve the early response rate in SAA/VSAA patients with manageable toxicity.
Authors
- Lele Zhang
- Weiwang Li
- Huang Jb
- Xinyu Zhao (ORCID: https://orcid.org/0000-0002-5128-4424)
- Xingxin Li
- Zhen Gao
- Lei Fang (ORCID: https://orcid.org/0000-0001-9980-8285)
- Zhexiang Kuang
- Neng Nie
- Meili Ge
- Jun Shi
- Jingyu Zhao
- Ruonan Li
- Jianping Li
- Hong Pan
- Yuan Li
- Yizhou Zheng
- Jing Zhang
- Xiao Yu
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Clinical Research (US)
- Institute of Hematology & Blood Diseases Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2026-01-30
- DOI
- https://doi.org/10.3389/fimmu.2026.1741042
- Primary Topic
- Hematopoietic Stem Cell Transplantation
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China
- Chinese Academy of Medical Sciences